3,4-dihydroxy-alpha-cyanocinnamamide,
3,4-dihydroxybenzylidene cyanoacetamide,
AG 99,
alpha-cyano-(3,4-dihydroxy)cinnamide,
tyrphostin 46,
tyrphostin A46,
tyrphostin AG99,
tyrphostin B40,
Tyrphostin 46,
Tyrphostin A46,
AG 99,
Tyrphostin B40,
122520-85-8,
AG-99,
alpha-Cyano-(3,4-dihydroxy)cinnamide,
3,4-Dihydroxy-alpha-cyanocinnamamide,
UNII-ARL2OF9022,
ARL2OF9022,
CHEMBL296407,
118409-59-9,
Tyrphostin AG 99,
(E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide,
NSC666250,
NSC-666250,
2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-,
(~{E})-3-[3,4-bis(oxidanyl)phenyl]-2-cyano-prop-2-enamide,
2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-, (2E)-,
Tyrphostin AG99,
3,4-Dihydroxy-alpha-cyanocinnamide,
NSC 666250,
Tocris-0497,
Tyrphostin deriv. 40,
AC1NS5AR,
BiomolKI_000013,
BiomolKI2_000023,
2-Cyano-3-(3,4-dihydroxyphenyl)-2-propenamide,
AG 99 (enzyme inhibitor),
BMK1-C1,
SCHEMBL242896,
BDBM4301,
ZINC15333,
HMS3678G17,
2086AH,
BS0019,
HSCI1_000130,
MFCD00133901,
NSC638077,
3,4-Dihydroxy-.alpha.-cyanocinnamide,
AKOS022488630,
CCG-100617,
NSC-638077,
NCGC00024616-01,
NCGC00024616-02,
benzylidenemalononitrile (BMN) deriv. 46,
ZB000734,
EC-000.2088,
(E)-2-cyano-3-(3,4-dihydroxyphenyl)acrylamide,
SR-01000597614,
J-003746,
SR-01000597614-1,
(2E)-2-cyano-3-(3,4-dihydroxyphenyl)prop-2-enamide,
BRD-K60184833-001-02-3,
BRD-K60184833-001-03-1,
(E)-2-CYANO-3-(3,4-DIHYDROXYPHENYL)-2-PROPENAMIDE,
D01NTW,
C10H8N2O3,
3,4-Dihydroxybenzylidene cyanoacetamide,
C10-H8-N2-O3,
CID5328768,
2-cyano-3-(3,4-dihydroxyphenyl)acrylamide,
JGB,